Welcome To Street Investment
By Admin
Posted on September 26, 2025
Sun Pharma share price target is being discussed a lot among investors as the company’s current price is ₹1,583.10 and its growth potential looks quite strong in the coming years. Sun Pharma is aggressively expanding in both its specialty medicines and global generic business. Along with this, the R&D pipeline and USFDA approvals are also preparing the company for a strong future. Forecasts suggest that Sun Pharma share price target is giving a bullish signal for long term investors and the stock is expected to reach ₹2,950 by 2030.
The Sun Pharma share price target is showing a bullish trend for 2025. The stock is expected to trade above its current level of ₹1,583.10 from September 2025. Strong demand and the expansion of the specialty segment are providing upward momentum to the Sun Pharma share price target 2025.
| Month | Expected Price (INR) |
|---|---|
| September | ₹1,585 – 1,600 |
| October | ₹1,610 – 1,625 |
| November | ₹1,640 – 1,655 |
| December | ₹1,670 – 1,690 |
The Sun Pharma share price target may see further upside in 2026. Growth in exports and approvals in US markets will be positive for the company. Therefore, the Sun Pharma share price target is expected to reach around ₹2,200 during 2026.
| Month | Expected Price (INR) |
|---|---|
| January | ₹1,710 – 1,725 |
| February | ₹1,750 – 1,765 |
| March | ₹1,790 – 1,805 |
| April | ₹1,830 – 1,850 |
| May | ₹1,870 – 1,885 |
| June | ₹1,910 – 1,930 |
| July | ₹1,950 – 1,970 |
| August | ₹1,990 – 2,010 |
| September | ₹2,030 – 2,050 |
| October | ₹2,080 – 2,100 |
| November | ₹2,150 – 2,170 |
| December | ₹2,180 – 2,200 |
The Sun Pharma share price target could strengthen further by 2027 as demand is steadily increasing in both domestic and global markets. Analysts expect the Sun Pharma share price target to reach ₹2,400 by 2027.
| Month | Expected Price (INR) |
|---|---|
| January | ₹2,220 – 2,235 |
| February | ₹2,250 – 2,265 |
| March | ₹2,280 – 2,295 |
| April | ₹2,310 – 2,325 |
| May | ₹2,340 – 2,355 |
| June | ₹2,360 – 2,375 |
| July | ₹2,370 – 2,385 |
| August | ₹2,380 – 2,395 |
| September | ₹2,390 – 2,405 |
| October | ₹2,395 – 2,410 |
| November | ₹2,400 – 2,415 |
| December | ₹2,400 – 2,420 |
ALSO READ: VMS TMT Ltd Share Price Target 2025, 2026, 2027, 2028, 2029, 2030 | Future Forecast, Monthly Outlook
The Sun Pharma share price target is projected to reach approximately ₹2,600 by 2028. Demand in specialty medicines and chronic therapies makes the Sun Pharma share price target 2028 an attractive opportunity for investors.
| Month | Expected Price (INR) |
|---|---|
| January | ₹2,430 – 2,445 |
| February | ₹2,460 – 2,475 |
| March | ₹2,490 – 2,505 |
| April | ₹2,520 – 2,535 |
| May | ₹2,550 – 2,565 |
| June | ₹2,570 – 2,585 |
| July | ₹2,580 – 2,595 |
| August | ₹2,590 – 2,605 |
| September | ₹2,595 – 2,610 |
| October | ₹2,600 – 2,615 |
| November | ₹2,605 – 2,620 |
| December | ₹2,610 – 2,625 |
ALSO READ: VMS TMT Ltd Share Price Target 2025, 2026, 2027, 2028, 2029, 2030 | Future Forecast, Monthly Outlook
The Sun Pharma share price target is estimated to reach ₹2,775 by 2029. New product launches and geographical expansion will be the major drivers during this period. The outlook for the Sun Pharma share price target 2029 appears quite positive.
| Month | Expected Price (INR) |
|---|---|
| January | ₹2,630 – 2,645 |
| February | ₹2,660 – 2,675 |
| March | ₹2,690 – 2,705 |
| April | ₹2,720 – 2,735 |
| May | ₹2,740 – 2,755 |
| June | ₹2,755 – 2,770 |
| July | ₹2,760 – 2,775 |
| August | ₹2,765 – 2,780 |
| September | ₹2,770 – 2,785 |
| October | ₹2,775 – 2,790 |
| November | ₹2,775 – 2,795 |
| December | ₹2,780 – 2,800 |
The Sun Pharma share price target 2030 shows a long term bullish trend. Analysts believe the stock could trade at ₹2,950 by its December 2030. The Sun Pharma share price target 2030 appears achievable due to strong R&D and international expansion.
| Month | Expected Price (INR) |
|---|---|
| January | ₹2,820 – 2,835 |
| February | ₹2,850 – 2,865 |
| March | ₹2,880 – 2,895 |
| April | ₹2,910 – 2,925 |
| May | ₹2,930 – 2,945 |
| June | ₹2,940 – 2,955 |
| July | ₹2,945 – 2,960 |
| August | ₹2,950 – 2,965 |
| September | ₹2,955 – 2,970 |
| October | ₹2,960 – 2,975 |
| November | ₹2,965 – 2,980 |
| December | ₹2,970 – 2,985 |
Overall, Sun Pharma’s share price target and forecasts both appear bullish. From the current level of ₹1,583.10, the stock is projected to grow to ₹2,950 by the end of its 2030. Strong pharmaceutical demand, international presence, and R&D pipeline are creating long term advantages for the company.
Disclaimer
These Sun Pharma share price target and its forecasts are based on market estimates. Actual prices may differ depending on market conditions and company performance.
Soheb is a content writer with 5+ years of experience and a trading educator for the past 2 years. He specializes in forex, crypto, share market investing, and swing trading. With a strong grasp on both writing and trading, he simplifies complex market concepts into practical insights for learners and investors alike.
